Target intelligence / Profile preview

Dengue virus serotype 3 capsid protein (DENV-3 C)

Target
DENV-3 C
Molecular classification
Viral structural protein, RNA-binding protein, Lipid-binding protein
01

Overview

The Dengue virus serotype 3 capsid protein (C protein) is a small, highly basic structural protein essential for the viral life cycle. Its primary role is to package the positive-sense single-stranded RNA genome into a nucleocapsid, which is then enveloped by a lipid bilayer containing the envelope (E) and membrane (M) proteins (UniProt: A0A7D8HXX1). Beyond its structural role, the C protein acts as an RNA chaperone and interacts with host cell components, most notably lipid droplets and very low-density lipoproteins (VLDL), to facilitate viral assembly and replication (Faustino et al., 2015, NIH: PMC4516019). It also plays a role in immune evasion by antagonizing host innate immune responses and serving as a signal peptide for the non-structural protein NS4B (UniProt: Q7T4M8). As a therapeutic target, the C protein is attractive due to its critical role in both the assembly of new virions and the uncoating of the viral genome during entry (Byrd et al., 2013, PubMed: 23114750). Small molecules like ST-148 have been shown to inhibit replication by inducing aberrant capsid self-interaction and tetramerization, while peptide leads like pep14-23 target the protein's interaction with host lipid droplets (Xia et al., 2020, PubMed: 32661167). However, challenges remain in developing pan-serotype inhibitors that can overcome the high genetic variability of the four dengue serotypes and the rapid emergence of resistance mutations, such as the S34L substitution (Byrd et al., 2013).

Other names
Capsid protein CCore proteinC proteinDENV3 CDengue virus type 3 capsid protein
02

Mechanism of action

Inhibition of capsid-lipid droplet interaction and enhancement of capsid self-interaction to perturb viral assembly and disassembly.

03

Biological functions

Viral genome packagingNucleocapsid assemblyRNA chaperone activityLipid droplet interactionImmune evasionSignal peptide for NS4B
04

Disease associations

Infection
05

Safety considerations

Drug resistance (e.g., S34L mutation)Serotype-specific efficacyPotential interference with host lipid metabolism
06

Interacting drugs

ST-148

1 more in the full profile.

07

Biomarkers

NS1 antigenViral RNA (RT-PCR)Anti-DENV IgMAnti-DENV IgG

Beyond the preview

Go deeper on Dengue virus serotype 3 capsid protein (DENV-3 C).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dengue virus serotype 3 capsid protein (DENV-3 C).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call